Antiretroviral Therapy News
- ART Associated With Less Risk of Preterm Birth in Large US Study
- PrEP Kidney Function Monitoring to Be Fine-Tuned
- HIV Preventive Care Is Supposed to Be Free in the US
- Protease Inhibitor Promising Against SARS-CoV-2 in Midstage Trial
- CROI 2022 Third Transplant Patient Cured of HIV Marks Important Firsts
- CROI 2022 16 Toddlers With HIV at Birth Had No Detectable Virus
- CAB-LA Cost Might Be a Deal-Breaker for Payers and Patients
- 1 in 12 Abandons HIV PrEP Prescriptions in US
- HIV Stigma Persists Globally, According to Harris Poll
- Early Research Suggests Merck Cancer Drug May Target Dormant HIV
- Gilead Says Counterfeiting Network Sold $250 Mln Worth of Its HIV Drugs
- HIV+ Patients Get Good Outcomes After Kidney or Liver Transplant
- Pfizer to Supply US With 10 Mln More Courses of COVID-19 Pills
- COVID-19 Vaccinations in People With HIV Match Community Rates
- HIV: FDA Stops All Islatravir Oral and Implant Trials
- COVID Vax Leads Rheumatology Patients to Modify Drug Regimens
- SABCS 2021 Vitamin D Counters Bone Density Loss With Aromatase Inhibitors
- USCHA 2021 Inadequate Routine Diabetes Screening Common in HIV
- New Trials in Urologic Cancers: Could Your Patient Benefit?
- SABCS 2021 Should CDK4/6 Inhibitors Be Stopped in the Face of COVID-19?
- Atopic Dermatitis: Expert Shares Parents' Top Five Questions